Company Overview
Snapshot
Founded in January 2015 by Yossi Gross and Danny Lange, Ph.D., ChroniSense Medical operates with 11–50 employees. The company has secured one funding round and holds a patent. In December 2022, ChroniSense Medical received FDA 510(k) clearance for its RPM wearable device.
Business overview
ChroniSense Medical develops the Polso wearable medical sensor platform, designed to provide accurate, reliable, multiparametric data for chronic disease management. This technology supports both continuous and spot-check patient monitoring in hospital and clinical settings, integrating with systems like NEWS. For home use, Polso enables medical-grade health monitoring, facilitating patient home discharge and reducing overall healthcare costs. The company operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices, Digital Healthcare, and Patient Remote Monitoring, utilizing sensing and artificial intelligence technologies.
Strategic signal
In December 2022, ChroniSense Medical received FDA 510(k) clearance for its remote patient monitoring (RPM) wearable device. This regulatory approval is a significant validation of the company's technology, enabling broader market access and commercialization within the US healthcare system. For investors, this signals a critical de-risking event and opens pathways for increased adoption in the rapidly growing remote care market.
Log in to access full profile ›Company Intelligence Q&A
- What is ChroniSense Medical's primary product?
- ChroniSense Medical's primary product is Polso, a wearable medical sensor platform designed for accurate, reliable, multiparametric data collection in chronic disease management.
- When was ChroniSense Medical founded?
- ChroniSense Medical was founded in January 2015.
- What significant regulatory milestone did ChroniSense Medical achieve recently?
- In December 2022, ChroniSense Medical received FDA 510(k) clearance for its remote patient monitoring (RPM) wearable device.
- Who are the founders of ChroniSense Medical?
- ChroniSense Medical was co-founded by Yossi Gross and Danny Lange, Ph.D.
- What was a key leadership change at ChroniSense Medical?
- In March 2020, ChroniSense Medical appointed a new CEO.